Results 1 to 10 of about 13,648 (298)

Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU

open access: yesUnited European Gastroenterology Journal, Volume 13, Issue 5, Page 674-684, June 2025.
ABSTRACT Background Leishmaniasis (LI) is a vector‐borne illness caused by a protozoan of the genus Leishmania. Data on the features of LI in patients with inflammatory bowel disease (IBD) are scarce. Aim To describe the characteristics of patients with IBD who present with leishmaniasis, infection outcomes and the risk factors associated with ...
L Madero‐Velázquez   +29 more
wiley   +1 more source

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection [PDF]

open access: yes, 2018
L
Altorjay, István   +17 more
core   +1 more source

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine

open access: yesDrug Design, Development and Therapy, 2011
Lilliana Oliveira, Russell D CohenThe Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Chicago, IL, USAAbstract: The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first ...
Lilliana Oliveira, Russell D Cohen
doaj  

Not Your Typical Ulcerative Colitis Patient [PDF]

open access: yesModern Medicine
Background: Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD.
Teodora SPATARU   +3 more
doaj   +1 more source

Anti-oxidant and anti-inflammatory potential of different polymer-based mesalamine delayed-release granules in TNBS-induced ulcerative colitis in wistar rats

open access: yesSaudi Pharmaceutical Journal
Ulcerative colitis (UC) is an inflammatory condition of colon characterized by severe damage to the innermost colon tissues. A number of studies described the use of medication delivery systems based on natural polymers like polysaccharides for the ...
Imtiyaz Ahmed Najar   +9 more
doaj  

Simple one-pot green method for large-scale production of mesalamine, an anti-inflammatory agent

open access: yesGreen Processing and Synthesis, 2019
We report a rapid and efficient synthesis protocol for mesalamine via a green approach with 2-chloro-5-nitrobenzoic acid as the starting material, for its large-scale production.
Vijaya Lakshmi C.   +2 more
doaj   +1 more source

The concurrent association of inflammatory polymyositis and Crohn’s ileo-colitis in a Sri Lankan man: a case report of a rare association and literature review [PDF]

open access: yes, 2014
BACKGROUND: Crohn’s disease is a relapsing, systemic inflammatory disease affecting the gastrointestinal tract with associated extraintestinal manifestations and immune disorders.
Champa Jayasundara   +3 more
core   +1 more source

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease

open access: yesJGH Open, 2019
Background and Aim The literature on medication adherence in patients with inflammatory bowel disease (IBD) is heterogeneous. The present study aimed to identify the rates and predictors of nonadherence to medications in IBD. Methods This cross‐sectional
Sanjeevani K Tomar   +10 more
doaj   +1 more source

How can you help prevent a recurrence of diverticulitis? [PDF]

open access: yes, 2009
A high-fiber diet is often prescribed after recovery from acute diverticulitis, based on extrapolation from epidemiologic data showing an association between low-fiber diets and diverticulosis (strength of recommendation [SOR]: C, expert opinion).
Jamieson, Barbara, Weisberger, Lise
core  

Home - About - Disclaimer - Privacy